CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- 4 Open-market sale Chief Technology Officer sold 82,368 shares at an average $17.46 ($1,438,038)
- 4 Open-market sale Chief Medical Officer sold 55,000 shares at an average $16.50 ($907,533)
- 4 Open-market sale Chief Scientific Officer sold 52,115 shares at an average $16.79 ($875,042)
- 4 Option exercise Director acquired 1,518,373 shares (option exercise)
- 4 Option exercise 10% owner acquired 1,518,373 shares (option exercise)
- 4 Open-market buy Director bought 205,721 shares at an average $20.87 ($4,293,545)
- 4 Option exercise Director acquired 2,359,500 shares (option exercise)
- 4 Open-market buy Director bought 8,016 shares at $12.72 ($101,968)
- 4 Open-market buy Director bought 7,500 shares at $12.70 ($95,250)
- 4 Grant or award Director acquired 2,359,500 shares (grant or award)
- 4 Grant or award Director acquired 5,933 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 753,781 shares (option exercise)
- 4 Option exercise Director acquired 3,418,617 shares (option exercise)
- 4 Option exercise Director acquired 148,710.49 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion 10% owner acquired 3,418,617 shares (conversion)
Page 4 of 21 · 410 filings